Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Age-Dependent Translocation of Gold Nanoparticles across the Air-Blood Barrier.

Tsuda A, Donaghey TC, Konduru NV, Pyrgiotakis G, Van Winkle LS, Zhang Z, Edwards P, Bustamante JM, Brain JD, Demokritou P.

ACS Nano. 2019 Sep 24;13(9):10095-10102. doi: 10.1021/acsnano.9b03019. Epub 2019 Aug 16.

PMID:
31397554
2.

Trypanosoma cruzi 13C-labeled O-Glycan standards for mass spectrometry.

Sheikh MO, Gas-Pascual E, Glushka JN, Bustamante JM, Wells L, West CM.

Glycobiology. 2019 Apr 1;29(4):280-284. doi: 10.1093/glycob/cwy111.

PMID:
30649355
3.

In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.

Strauss M, Rodrigues JHS, Lo Presti MS, Bazán PC, Báez AL, Paglini-Oliva P, Nakamura CV, Bustamante JM, Rivarola HW.

Exp Parasitol. 2018 Jun;189:19-27. doi: 10.1016/j.exppara.2018.04.016. Epub 2018 Apr 18.

PMID:
29726395
4.

Diagnosis of Trypanosoma cruzi Infection Status using Saliva of Infected Subjects.

Cortes-Serra N, Pinazo MJ, de la Torre L, Galizzi M, Gascon J, Bustamante JM.

Am J Trop Med Hyg. 2018 Feb;98(2):464-467. doi: 10.4269/ajtmh.17-0141. Epub 2018 Jan 4.

5.

Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.

Soares Medeiros LC, South L, Peng D, Bustamante JM, Wang W, Bunkofske M, Perumal N, Sanchez-Valdez F, Tarleton RL.

MBio. 2017 Nov 7;8(6). pii: e01788-17. doi: 10.1128/mBio.01788-17.

6.

Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.

Rosenberg CS, Zhang W, Bustamante JM, Tarleton RL.

Infect Immun. 2016 Aug 19;84(9):2627-38. doi: 10.1128/IAI.00241-16. Print 2016 Sep.

7.

Potential new clinical therapies for Chagas disease.

Bustamante JM, Tarleton RL.

Expert Rev Clin Pharmacol. 2014 May;7(3):317-25. doi: 10.1586/17512433.2014.909282. Epub 2014 Apr 9. Review.

PMID:
24716790
8.

Evidence for the role of vacuolar soluble pyrophosphatase and inorganic polyphosphate in Trypanosoma cruzi persistence.

Galizzi M, Bustamante JM, Fang J, Miranda K, Soares Medeiros LC, Tarleton RL, Docampo R.

Mol Microbiol. 2013 Nov;90(4):699-715. doi: 10.1111/mmi.12392. Epub 2013 Sep 30.

9.

New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.

Bustamante JM, Craft JM, Crowe BD, Ketchie SA, Tarleton RL.

J Infect Dis. 2014 Jan 1;209(1):150-62. doi: 10.1093/infdis/jit420. Epub 2013 Aug 14.

10.

Report of the 2nd Chagas Drug Discovery Consortium meeting, held on 3 November 2010; Atlanta GA, USA.

Bustamante JM, Park HJ, Tarleton RL; The Chagas Drug Discovery Consortium.

Expert Opin Drug Discov. 2011 Sep;6(9):965-73. doi: 10.1517/17460441.2011.602063. Epub 2011 Jul 19.

PMID:
22646217
11.

Thermophilic fungi in an aridland ecosystem.

Powell AJ, Parchert KJ, Bustamante JM, Ricken JB, Hutchinson MI, Natvig DO.

Mycologia. 2012 Jul-Aug;104(4):813-25. doi: 10.3852/11-298. Epub 2012 Apr 13.

PMID:
22505432
12.

Methodological advances in drug discovery for Chagas disease.

Bustamante JM, Tarleton RL.

Expert Opin Drug Discov. 2011 Jun;6(6):653-661.

13.

Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge.

Collins MH, Craft JM, Bustamante JM, Tarleton RL.

Infect Immun. 2011 Aug;79(8):3397-406. doi: 10.1128/IAI.01080-10. Epub 2011 May 31.

14.

In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.

Canavaci AM, Bustamante JM, Padilla AM, Perez Brandan CM, Simpson LJ, Xu D, Boehlke CL, Tarleton RL.

PLoS Negl Trop Dis. 2010 Jul 13;4(7):e740. doi: 10.1371/journal.pntd.0000740.

15.

In vitro and in vivo experimental models for drug screening and development for Chagas disease.

Romanha AJ, Castro SL, Soeiro Mde N, Lannes-Vieira J, Ribeiro I, Talvani A, Bourdin B, Blum B, Olivieri B, Zani C, Spadafora C, Chiari E, Chatelain E, Chaves G, Calzada JE, Bustamante JM, Freitas-Junior LH, Romero LI, Bahia MT, Lotrowska M, Soares M, Andrade SG, Armstrong T, Degrave W, Andrade Zde A.

Mem Inst Oswaldo Cruz. 2010 Mar;105(2):233-8.

16.

Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines.

Aponte JC, Vaisberg AJ, Castillo D, Gonzalez G, Estevez Y, Arevalo J, Quiliano M, Zimic M, Verástegui M, Málaga E, Gilman RH, Bustamante JM, Tarleton RL, Wang Y, Franzblau SG, Pauli GF, Sauvain M, Hammond GB.

Bioorg Med Chem. 2010 Apr 15;18(8):2880-6. doi: 10.1016/j.bmc.2010.03.018. Epub 2010 Mar 12.

PMID:
20356752
17.

CD8+ T cells in Trypanosoma cruzi infection.

Padilla AM, Bustamante JM, Tarleton RL.

Curr Opin Immunol. 2009 Aug;21(4):385-90. doi: 10.1016/j.coi.2009.07.006. Epub 2009 Jul 29. Review.

18.

Some components of the cardiac β-adrenergic system are altered in the chronic indeterminate form of experimental Trypanosoma cruzi infection.

Silvina Lo Presti M, Walter Rivarola H, Bustamante JM, Fernández AR, Enders JE, Levin G, Juaneda E, Fretes R, Fernanda Triquell M, Paglini-Oliva PA.

Int J Parasitol. 2008 Nov;38(13):1481-92. doi: 10.1016/j.ijpara.2008.04.009. Epub 2008 May 21.

PMID:
18582889
19.

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.

Bustamante JM, Bixby LM, Tarleton RL.

Nat Med. 2008 May;14(5):542-50. doi: 10.1038/nm1744. Epub 2008 Apr 20.

20.

Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.

Bustamante JM, Presti MS, Rivarola HW, Fernández AR, Enders JE, Fretes RE, Paglini-Oliva P.

Int J Antimicrob Agents. 2007 Jun;29(6):733-7. Epub 2007 Mar 28.

PMID:
17395432
21.

Reinfections and Trypanosoma cruzi strains can determine the prognosis of the chronic chagasic cardiopathy in mice.

Bustamante JM, Novarese M, Rivarola HW, Lo Presti MS, Fernández AR, Enders JE, Fretes R, Paglini-Oliva PA.

Parasitol Res. 2007 May;100(6):1407-10. Epub 2007 Feb 15.

PMID:
17372764
22.

Changes in the cardiac beta-adrenergic system provoked by different T. cruzi strains.

Lo Presti MS, Bustamante JM, Rivarola WH, Fernández AR, Enders JE, Fretes R, Levin G, Paglini-Oliva PA.

Int J Cardiol. 2006 Jul 28;111(1):104-12. Epub 2005 Oct 24.

PMID:
16246441
23.

Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area.

Rivarola HW, Bustamante JM, Lo Presti S, Fernández AR, Enders JE, Gea S, Fretes R, Paglini-Oliva P.

Exp Parasitol. 2005 Oct;111(2):80-6.

PMID:
16085036
24.

Weekly electrocardiographic pattern in mice infected with two different Trypanosoma cruzi strains.

Bustamante JM, Rivarola HW, Fretes R, Paglini-Oliva PA.

Int J Cardiol. 2005 Jul 10;102(2):211-7.

PMID:
15982487
25.

Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.

Lo Presti MS, Rivarola HW, Bustamante JM, Fernández AR, Enders JE, Fretes R, Gea S, Paglini-Oliva PA.

Int J Antimicrob Agents. 2004 Jun;23(6):634-6.

PMID:
15194137
26.

Electrocardiographic characterization in Trypanosoma cruzi reinfected mice.

Bustamante JM, Rivarola HW, Palma JA, Paglini-Oliva PA.

Parasitology. 2004 Apr;128(Pt 4):415-9.

PMID:
15151147
27.

Trypanosoma cruzi reinfections provoke synergistic effect and cardiac beta-adrenergic receptors' dysfunction in the acute phase of experimental Chagas' disease.

Bustamante JM, Rivarola HW, Fernández AR, Enders JE, Ricardo F, d'Oro Gloria DL, Palma JA, Paglini-Oliva PA.

Exp Parasitol. 2003 Mar-Apr;103(3-4):136-42.

PMID:
12880590
28.

Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.

Bustamante JM, Rivarola HW, Fernández AR, Enders JE, Fretes R, Palma JA, Paglini-Oliva PA.

Clin Sci (Lond). 2003 Apr;104(4):415-20.

PMID:
12653687
29.

Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage.

Bustamante JM, Rivarola HW, Fernández AR, Enders JE, Fretes R, Palma JA, Paglini-Oliva PA.

Int J Parasitol. 2002 Jun 15;32(7):889-96.

PMID:
12062560
30.

Profisetinidin type tannins responsible for antioxidant activity in Copaifera reticulata.

Desmarchelier CJ, Bustamante JM, Gil RR, Coussio JD, Ciccia GN, Silva GL.

Pharmazie. 2001 Jul;56(7):573-7.

PMID:
11487978
31.

Synthesis of (+/-)-11alpha-hydroxy-3-oxo-6alphaH,7alphaH, 10betaMe-eudesman-1,2-4,5-dien-6,12-olide.

Moreno-Dorado FJ, Guerra FM, Aladro FJ, Bustamante JM, Jorge ZD, Massanet GM.

J Nat Prod. 2000 Jul;63(7):934-8.

PMID:
10924168

Supplemental Content

Loading ...
Support Center